HAI
ALXN

Hennessy Advisors Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

Hennessy Advisors Inc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,260
Closed -$629K – 446
2017
Q4 		$629K Buy
+5,260
New +$641K 0.02% 305
2014
Q2 		– Sell
-1,920
Closed -$292K – 310
2014
Q1 		$292K Sell
1,920
-85
-4% -$13.5K 0.01% 299
2013
Q4 		$267K Sell
2,005
-125
-6% -$15K 0.01% 312
2013
Q3 		$247K Buy
+2,130
New +$234K 0.01% 314

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return